Published in HPB (Oxford) on January 01, 2008
Transcatheter arterial chemoembolization: history for more than 30 years. ISRN Gastroenterol (2012) 0.91
Pyogenic abscess after hepatic artery embolization: a rare but potentially lethal complication. J Vasc Interv Radiol (2010) 0.91
Hepatic arterial therapy with drug-eluting beads in the management of metastatic bronchogenic carcinoma to the liver: a multi-institutional registry. J Oncol (2012) 0.78
Short-term effectiveness of radiochemoembolization for selected hepatic metastases with a combination protocol. World J Gastroenterol (2012) 0.78
Hepatic arterial therapy with drug-eluting beads in the management of metastatic pancreatic carcinoma to the liver: a multi-institutional registry. J Oncol (2012) 0.77
Hepatic parenchymal changes following transcatheter embolization and chemoembolization in a rabbit tumor model. PLoS One (2013) 0.75
Adult Embryonal Sarcoma of the Liver: Management of a Massive Liver Tumor. Case Rep Surg (2016) 0.75
Gene Signature Associated with Upregulation of the Wnt/β-Catenin Signaling Pathway Predicts Tumor Response to Transarterial Embolization. J Vasc Interv Radiol (2017) 0.75
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst (2000) 133.74
Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol (1982) 43.81
Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med (2007) 30.94
A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. N Engl J Med (2003) 14.59
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet (2002) 12.16
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology (2003) 11.55
Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology (2002) 9.76
A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire. N Engl J Med (1995) 6.75
Updated treatment approach to hepatocellular carcinoma. J Gastroenterol (2005) 3.43
Measuring response in a post-RECIST world: from black and white to shades of grey. Nat Rev Cancer (2006) 3.06
Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents. Radiology (1987) 1.73
Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors. Cancer (1995) 1.65
Transcatheter and ablative therapeutic approaches for solid malignancies. J Clin Oncol (2007) 1.59
Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal. Br J Surg (1995) 1.58
Randomized discontinuation design: application to cytostatic antineoplastic agents. J Clin Oncol (2002) 1.54
Combined peripheral and central chemoembolization of liver tumors. Experience with lipiodol-doxorubicin and gelatin sponge (L-TAE). Cancer (1988) 1.39
Selective effects of Lipiodolized antitumor agents. J Surg Oncol (1984) 1.23
Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors. A prospective phase II study in 24 patients. Cancer (1993) 1.23
Regression of ocular melanoma metastatic to the liver after hepatic arterial chemoembolization with cisplatin and polyvinyl sponge. JAMA (1988) 1.20
Colorectal liver metastases: regional chemotherapy via transarterial chemoembolization (TACE) and hepatic chemoperfusion: an update. Eur Radiol (2006) 1.19
Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution. J Vasc Interv Radiol (2005) 1.15
Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature. Cancer (1998) 1.14
Postoperative adjuvant hepatic arterial infusion of Lipiodol containing anticancer drugs in patients with hepatocellular carcinoma. Hepatology (1994) 1.13
Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver. J Vasc Interv Radiol (2007) 1.09
Chemoembolization in the management of liver tumors. Oncologist (2003) 1.07
Transcatheter chemoembolization of progressive carcinoid liver metastasis. Radiology (1993) 1.06
An appraisal of transcatheter arterial embolization combined with transcatheter arterial infusion of chemotherapeutic agent for hepatic malignancies. World J Surg (1982) 1.05
Chemoembolization of hepatocellular carcinoma with cisplatin, doxorubicin, mitomycin-C, ethiodol, and polyvinyl alcohol: prospective evaluation of response and survival in a U.S. population. J Vasc Interv Radiol (1999) 0.95
Hepatic arterial chemoembolization for metastatic neuroendocrine tumors. Digestion (1994) 0.94
Hepatic artery embolization for inoperable hepatocellular carcinoma; prognosis and risk factors. Cancer Chemother Pharmacol (1989) 0.91
Chemoembolization of liver metastasis from breast carcinoma. J Vasc Interv Radiol (2004) 0.88
Hepatic arterial chemotherapy and occlusion for palliation of primary hepatocellular and unknown primary neoplasms in the liver. Cancer (1983) 0.87
Ablative therapies for liver metastases of gastroenteropancreatic endocrine tumors. Neuroendocrinology (2004) 0.87
Colorectal metastases to the liver: selective chemoembolization. Radiology (1993) 0.86
Preliminary experience with transarterial chemoembolization (TACE) in liver metastases of uveal malignant melanoma: local tumor control and survival. J Cancer Res Clin Oncol (2006) 0.85
A prospective randomized evaluation of a compound of tegafur and uracil as an adjuvant chemotherapy for hepatocellular carcinoma treated with transcatheter arterial chemoembolization. Am J Clin Oncol (1995) 0.84
Hepatic artery chemoembolization. Semin Oncol (2002) 0.84
Cost-effectiveness of hepatic arterial chemoembolization for colorectal liver metastases refractory to systemic chemotherapy. Radiology (2000) 0.82
Chemoembolization for liver metastases from colorectal carcinoma: risk or a benefit. Neoplasma (2002) 0.79
Atomic structures of amyloid cross-beta spines reveal varied steric zippers. Nature (2007) 10.02
Cardiovascular disease in kidney donors: matched cohort study. BMJ (2012) 5.00
Maize HapMap2 identifies extant variation from a genome in flux. Nat Genet (2012) 3.74
Health related quality of life after combined hormone replacement therapy: randomised controlled trial. BMJ (2008) 3.56
Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transplant (2010) 2.70
Improved survival with adjuvant external-beam radiation therapy in lymph node-negative pancreatic cancer: a United States population-based assessment. Cancer (2008) 2.19
Acute liver failure induced by green tea extracts: case report and review of the literature. Liver Transpl (2006) 2.13
Prevalence of BRCA mutations and founder effect in high-risk Hispanic families. Cancer Epidemiol Biomarkers Prev (2005) 2.00
Molecular mechanisms for protein-encoded inheritance. Nat Struct Mol Biol (2009) 1.94
An expectation-maximization algorithm for probabilistic reconstructions of full-length isoforms from splice graphs. Nucleic Acids Res (2006) 1.90
Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States. Cancer (2010) 1.87
Quality of life outcomes in 599 cancer and non-cancer patients with colostomies. J Surg Res (2006) 1.83
Transferable anticancer innate immunity in spontaneous regression/complete resistance mice. Proc Natl Acad Sci U S A (2006) 1.77
Evaluation of absolute serum α-fetoprotein levels in liver transplant for hepatocellular cancer. Arch Surg (2011) 1.60
Acute dialysis risk in living kidney donors. Nephrol Dial Transplant (2012) 1.60
Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: direct quantitative PCR for ALU repeats. Clin Chem (2006) 1.58
Living kidney donor follow-up: state-of-the-art and future directions, conference summary and recommendations. Am J Transplant (2011) 1.51
Adjuvant chemotherapy improves survival in patients with American Joint Committee on Cancer stage II colon cancer. Cancer (2011) 1.49
The structural biology of protein aggregation diseases: Fundamental questions and some answers. Acc Chem Res (2006) 1.47
Metastatic gastrointestinal stromal tumors in the era of imatinib: improved survival and elimination of socioeconomic survival disparities. Cancer Epidemiol Biomarkers Prev (2008) 1.46
Genome-wide analysis of aromatase inhibitor-resistant, tamoxifen-resistant, and long-term estrogen-deprived cells reveals a role for estrogen receptor. Cancer Res (2008) 1.44
Neoadjuvant therapy is associated with improved survival in resectable pancreatic adenocarcinoma. Cancer (2010) 1.41
Discovery of N-phenyl nicotinamides as potent inhibitors of Kdr. Bioorg Med Chem Lett (2007) 1.39
Total pancreatectomy and autologous islet cell transplantation as a means to treat severe chronic pancreatitis. J Gastrointest Surg (2003) 1.35
Utility of circulating B-RAF DNA mutation in serum for monitoring melanoma patients receiving biochemotherapy. Clin Cancer Res (2007) 1.33
Small-molecule agonists of SHIP1 inhibit the phosphoinositide 3-kinase pathway in hematopoietic cells. Blood (2007) 1.28
miRNA signature associated with outcome of gastric cancer patients following chemotherapy. BMC Med Genomics (2011) 1.28
Cardiac function during steep Trendelenburg position and CO2 pneumoperitoneum for robotic-assisted prostatectomy: a trans-oesophageal Doppler probe study. Int J Med Robot (2007) 1.24
Aberrant hypermethylation of ID4 gene promoter region increases risk of lymph node metastasis in T1 breast cancer. Oncogene (2005) 1.24
FXR regulates liver repair after CCl4-induced toxic injury. Mol Endocrinol (2010) 1.23
Hospitalized heart failure: rates and long-term mortality. J Card Fail (2004) 1.19
High mobility group A2 potentiates genotoxic stress in part through the modulation of basal and DNA damage-dependent phosphatidylinositol 3-kinase-related protein kinase activation. Cancer Res (2005) 1.18
The impact of lymph node number on survival in patients with lymph node-negative pancreatic cancer. Pancreas (2008) 1.17
Epigenetic up-regulation of C-C chemokine receptor 7 and C-X-C chemokine receptor 4 expression in melanoma cells. Cancer Res (2005) 1.15
The G691S RET polymorphism increases glial cell line-derived neurotrophic factor-induced pancreatic cancer cell invasion by amplifying mitogen-activated protein kinase signaling. Cancer Res (2005) 1.14
Socioeconomic factors impact colon cancer outcomes in diverse patient populations. J Gastrointest Surg (2012) 1.13
Comparative study of Kaposi's sarcoma-associated herpesvirus serological assays using clinically and serologically defined reference standards and latent class analysis. J Clin Microbiol (2006) 1.10
The impact of prostate gland weight in robot assisted laparoscopic radical prostatectomy. J Urol (2008) 1.08
A Phase 1, Dose-escalation, Double-blind, Block-randomized, Controlled Trial of Safety and Efficacy of Neosaxitoxin Alone and in Combination with 0.2% Bupivacaine, with and without Epinephrine, for Cutaneous Anesthesia. Anesthesiology (2015) 1.08
Evidence-based gallbladder cancer staging: changing cancer staging by analysis of data from the National Cancer Database. Ann Surg (2006) 1.08
Prognostic and predictive roles of KRAS mutation in colorectal cancer. Int J Mol Sci (2012) 1.07
X-Linked inhibitor of apoptosis protein expression level in colorectal cancer is regulated by hepatocyte growth factor/C-met pathway via Akt signaling. Clin Cancer Res (2005) 1.07
Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells. J Transl Med (2012) 1.06
Totally laparoscopic gastric resection with extended lymphadenectomy for gastric adenocarcinoma. Ann Surg Oncol (2009) 1.05
Distinctions in gastric cancer gene expression signatures derived from laser capture microdissection versus histologic macrodissection. BMC Med Genomics (2011) 1.04
In vitro selection of external guide sequences for directing RNase P-mediated inhibition of viral gene expression. J Biol Chem (2002) 1.03
Symptom concerns and quality of life in hepatobiliary cancers. Oncol Nurs Forum (2008) 1.02
Distribution of residual cancer cells in the bowel wall after neoadjuvant chemoradiation in patients with rectal cancer. Dis Colon Rectum (2013) 1.01
Acute lung injury induces cardiovascular dysfunction: effects of IL-6 and budesonide/formoterol. Am J Respir Cell Mol Biol (2010) 1.01
Reduced morbidity following cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion. Ann Surg Oncol (2004) 1.00
Molecular mechanisms of metastasis. Cancer Metastasis Rev (2006) 1.00
The anatomic location of pancreatic cancer is a prognostic factor for survival. HPB (Oxford) (2008) 1.00
Hemoglobin variability does not predict mortality in European hemodialysis patients. J Am Soc Nephrol (2010) 1.00
The HIV positive selection mutation database. Nucleic Acids Res (2006) 0.99
Plant defense genes associated with quantitative resistance to potato late blight in Solanum phureja x dihaploid S. tuberosum hybrids. Mol Plant Microbe Interact (2002) 0.98
Chemokine receptor CXCR4 enhances proliferation in pancreatic cancer cells through AKT and ERK dependent pathways. Pancreas (2010) 0.97
Improved outcomes in the management of esophageal cancer with the addition of surgical resection to chemoradiation therapy. Ann Surg Oncol (2010) 0.95
Development and regulation of traditional Chinese medicine practitioners in Hong Kong. Perspect Public Health (2009) 0.94
The Wide-Awake Approach to Dupuytren's Disease: Fasciectomy under Local Anesthetic with Epinephrine. Hand (N Y) (2009) 0.93
Characterization and fine-mapping of a resistance locus for northern leaf blight in maize bin 8.06. Theor Appl Genet (2010) 0.93
Methadone antinociception is dependent on peripheral opioid receptors. J Pain (2009) 0.93
Opportunities for minimization of confounding in observational research. Pharm Stat (2011) 0.92
Phase II study of oxaliplatin in patients with unresectable, metastatic, or recurrent hepatocellular cancer: a California Cancer Consortium Trial. Am J Clin Oncol (2008) 0.91
Targeted therapies in colorectal cancer: surgical considerations. J Gastrointest Oncol (2013) 0.90
CC chemokine receptor 9 enhances proliferation in pancreatic intraepithelial neoplasia and pancreatic cancer cells. J Gastrointest Surg (2009) 0.89
An epidemiological study of hemodialysis patients based on the European Fresenius Medical Care hemodialysis network: results of the ARO study. Nephron Clin Pract (2010) 0.89
Four-arm robotic partial nephrectomy for complex renal cell carcinoma. World J Urol (2009) 0.89
Molecular markers for gastric adenocarcinoma: an update. Mol Diagn Ther (2006) 0.88
Gene polymorphisms predict toxicity to neoadjuvant therapy in patients with rectal cancer. Cancer (2012) 0.88
Minimally invasive total gastrectomy for gastric cancer: a pilot series. J Gastrointest Surg (2010) 0.88
Do selected drugs increase the risk of lupus? A matched case-control study. Br J Clin Pharmacol (2010) 0.88
Molecular diagnosis of response to neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer. J Am Coll Surg (2011) 0.87
Phase I study of pazopanib in patients with advanced solid tumors and hepatic dysfunction: a National Cancer Institute Organ Dysfunction Working Group study. Clin Cancer Res (2013) 0.87
Targeted discovery of quantitative trait loci for resistance to northern leaf blight and other diseases of maize. Theor Appl Genet (2011) 0.87
Concerns of family caregivers of patients with cancer facing palliative surgery for advanced malignancies. Oncol Nurs Forum (2003) 0.87
Analysis of factors influencing outcome in patients with in-transit malignant melanoma undergoing isolated limb perfusion using modern treatment parameters. J Clin Oncol (2009) 0.87
Short- and long-term outcomes of intracorporeal versus extracorporeal ileocolic anastomosis in laparoscopic right hemicolectomy for colon cancer. Surg Endosc (2013) 0.86
In vitro, ex vivo and in vivo immunopharmacological activities of the isoxazoline compound VGX-1027: modulation of cytokine synthesis and prevention of both organ-specific and systemic autoimmune diseases in murine models. Clin Immunol (2007) 0.86
A disease-based comparison of liver transplantation outcomes. Am Surg (2009) 0.85
The association of hospital volume with rectal cancer surgery outcomes. Int J Colorectal Dis (2012) 0.84
Evaluation of lymphadenectomy in patients receiving neoadjuvant radiotherapy for rectal adenocarcinoma. Ann Surg Oncol (2012) 0.84
Krukenberg tumors from colorectal cancer: presentation, treatment and outcomes. Am Surg (2011) 0.84
Milan Criteria and UCSF Criteria: A Preliminary Comparative Study of Liver Transplantation Outcomes in the United States. Int J Hepatol (2012) 0.84
Mutations in specific codons of the KRAS oncogene are associated with variable resistance to neoadjuvant chemoradiation therapy in patients with rectal adenocarcinoma. Ann Surg Oncol (2013) 0.84
Engineered RNase P ribozymes are efficient in cleaving a human cytomegalovirus mRNA in vitro and are effective in inhibiting viral gene expression and growth in human cells. J Biol Chem (2003) 0.84
A potent immunomodulatory compound, (S,R)-3-Phenyl-4,5-dihydro-5-isoxazole acetic acid, prevents spontaneous and accelerated forms of autoimmune diabetes in NOD mice and inhibits the immunoinflammatory diabetes induced by multiple low doses of streptozotocin in CBA/H mice. J Pharmacol Exp Ther (2006) 0.84
A phase I and pharmacokinetic study of oral 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced-stage solid cancers: a California Cancer Consortium Study. Cancer Chemother Pharmacol (2011) 0.84
Safety of outpatient laparoscopic cholecystectomy in the elderly: analysis of 15,248 patients using the NSQIP database. J Am Coll Surg (2013) 0.84
Systematic review on the efficacy and safety of herbal medicines for Alzheimer's disease. J Alzheimers Dis (2008) 0.84
Exposure to monomethylarsonous acid (MMA(III)) leads to altered selenoprotein synthesis in a primary human lung cell model. Toxicol Appl Pharmacol (2008) 0.83
Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus. Int Urol Nephrol (2012) 0.83
TP53 and let-7a micro-RNA regulate K-Ras activity in HCT116 colorectal cancer cells. PLoS One (2013) 0.83
Chinese medicine: its role and application in the institutionalised older people. J Clin Nurs (2010) 0.82